Neonatal diabetes mellitus due to pancreas agenesis: A new case report and review of the literature

Pediatric Diabetes

Volumn 10, Issue 7, 2009, Pages 487-491

  Seick Barbarini, Daniela ^a   Haslinger, Vera ^a   Schmidt, Katerina ^a   Patch, Ann Marie ^b   Müller, Guido ^a   Simma, Burkhard ^a  

^a Landeskrankenhaus Feldkirch   (Austria)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Hyperglycemia; Insulin; Neonate; Pancreatic agenesis; Pancreatic insufficiency

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; KREON; NEUTRAL INSULIN; PANCREAS ENZYME; ANTIDIABETIC AGENT; INSULIN, NEUTRAL;

AGENESIS; ARTICLE; CASE REPORT; CHILD; CONGENITAL DIAPHRAGM HERNIA; DEVELOPMENT; DIABETES MELLITUS; ENDOCRINE DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN PUMP; INSULIN TREATMENT; INTRAUTERINE GROWTH RETARDATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS MALFORMATION; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; SURVIVAL; THORAX RADIOGRAPHY; VITAMIN SUPPLEMENTATION; CESAREAN SECTION; CONGENITAL MALFORMATION; HYPERGLYCEMIA; INFANT; NEWBORN; NEWBORN DISEASE; PANCREAS; PATHOLOGY; RECURRENT DISEASE; REMISSION; REVIEW;

CESAREAN SECTION; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INSULIN; MAGNETIC RESONANCE IMAGING; PANCREAS; RECURRENCE; REMISSION, SPONTANEOUS;

EID: 75549091266     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00523.x     Document Type: Article

References (40)

1. von Mühlendahl KE, Herkenhoff H. Long-term course of neonatal diabetes. N Engl J Med 1995, 333:704-708.
2. Gloyn AL, Pearson ER, Antcliff JF. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838-1849.
3. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006, 7:352-360.
4. Shield JPH, Gardner RJ, Wadsworth EJK. Aetiopathology and genetics basis of neonatal diabetes. Arch Dis Child 1997, 76:F39-F42.
5. Metz C, Cavé H, Bertrand AM. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 2002, 141:483-489.
6. Temple IK, Gardner RJ, Mackay DJG, Barber JCK, Robinson DO, Shield JPH. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000, 49:1359-1366.
7. Massa O, Iafusco D, D'Amato E. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mut 2005, 25:22-27.
8. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006, 49:1190-1197.
9. Stanik J, Gasperikova D, Paskova M. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrin Metab 2007, doi:10.1210/jc.2006-2490
10. Rica I, Luzuriaga C, Pérez de Nanclares G. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities. Diabet Med 2007, 24:707-713.
11. Gloyn AL, Reimann F, Girard C. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 2005, 14:925-934.
12. Babenko AP, Polak M, Cavé H. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006, 355:456-466.
13. Lemons JA, Ridenour R, Orsini EN. Congenital absence of the pancreas and intrauterine growth retardation. Pediatrics 1979, 64:255-256.
14. Howard CP, Go VLW, Infante AJ. Long-term survival in a case of functional pancreatic agenesis. J Pediatr 1980, 97:786-789.
15. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence [letter]. Nat Genet 1997, 15:106-110.
16. Verwest AM, Poelman M, Dinjens WNM. Absence of a PDX-1 mutation and normal gastroduodenal immunohistology in a child with pancreatic agenesis. Virchows Arch 2000, 437:680-684.
17. Schwitzgebel VM, Mamin A, Brun T. Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. J Clin Endocrinol Metab 2003, 88:4398-4406.
18. Sellick GS, Barker KT, Stolte-Dijkstra I. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004, 36:1301-1305. doi:10.1038/ng1475
19. Baumeister FAM, Engelsberger I, Schulze A. Pancreatic agenesis as cause for neonatal diabetes mellitus. Klin Padiatr 2005, 217:76-81.
20. Ashraf A, Abdullatif H, Hardin W, Moates JM. Unusual case of neonatal diabetes mellitus due to congenital pancreas agenesis. Pediatr Diabetes 2005, 6:239-243.
21. Chen R, Hussain K, Al-Ali M. Neonatal and late-onset diabetes mellitus caused by failure of pancreatic development: report of 4 more cases and a review of the literature. Pediatrics 2008, 121:e1541-e1547.
22. Mitchell J, Punthakee Z, Lo B. Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome. Diabetologia 2004, 47:2160-2167.
23. Njølstad PR, Sagen JV, Bjørkhaug L. Permanent neonatal diabetes caused by glucokinase deficiency. Inborn error of the glucose-insulin signalling pathway. Diabetes 2003, 52:2854-2860.
24. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545. doi. 10.1136/jmg.39.8.537
25. Delépine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome [letter]. Nat Genet 2000, 25:406-409.
26. Senée V, Vattem KM, Delépine M. Wolcott-Rallison syndrome. Clinical, genetic and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004, 53:1876-1883.
27. Yorifuji T, Kurokawa K, Mamada M. Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1β gene due to germline mosaicism. J Clin Endocrinol Metab 2004, 89:2905-2908.
28. Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide AL, Cereghini S. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1β/MODY5 mutations [abstract]. Hum Mol Genet 2006, 15:2363-2375.
29. Edghill EL, Bingham C, Slingerland AS. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet Med 2006, 23:1301-1306.
30. Senée V, Chelala C, Duchatelet S. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism [abstract]. Nat Genet 2006, 38:682-687.
31. Shield JPH. Neonatal diabetes: how research unravelling the genetic puzzle has both widened our understanding of pancreatic development whilst improving children's quality of life. Horm Res 2007, 67:77-83. doi:10.1159/000096354
32. Sperling MA. ATP-sensitive potassium channels-neonatal diabetes mellitus and beyond [editorials]. N Engl J Med 2006, 355:507-510.
33. Slingerland AS, Hattersley AT. Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth and also cause neonatal diabetes. J Clin Endocrinol Metab 2006, 91:2782-2788.
34. Fowden A. The role of insulin in fetal growth. Early Hum Dev 1992, 29:177-181.
35. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997, 48:11-16. (Suppl. 1):
36. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 2004, 47:597-613.
37. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997, 17:138-139.
38. Hani EH, Stoffers DA, Chévre JC. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999, 104:R41-R48.
39. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin promoter factor-1 is required for pancreas development in mice. Nature 1994, 371:606-609.
40. Haumaitre C, Barbacci E, Jenny M, Ott MO, Gradwohl G, Cereghini S. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc Natl Acad Sci U S A 2005, 102:1490-1495. doi:10.1073/pnas.0405776102